Net Income (Loss) Attributable to Parent in USD of Biofrontera Inc. from Q3 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Biofrontera Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q3 2020 to Q3 2025.
  • Biofrontera Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2025 was -$6.65M, a 17.3% decline year-over-year.
  • Biofrontera Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2025 was -$17.6M, a 36.9% decline year-over-year.
  • Biofrontera Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$17.8M, a 11.8% increase from 2023.
  • Biofrontera Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$20.1M, a 3045% decline from 2022.
  • Biofrontera Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$640K, a 98.3% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

Biofrontera Inc. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$17.6M -$6.65M -$980K -17.3% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-12
Q2 2025 -$16.6M -$5.32M -$5.07M -1972% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-13
Q1 2025 -$11.5M -$4.2M +$6.23M +59.7% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-15
Q4 2024 -$17.8M -$1.4M -$4.92M -140% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-20
Q3 2024 -$12.8M -$5.67M +$673K +10.6% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-12
Q2 2024 -$13.5M -$257K +$9.58M +97.4% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-13
Q1 2024 -$23.1M -$10.4M -$2.96M -39.6% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-15
Q4 2023 -$20.1M $3.53M +$6.31M Oct 1, 2023 Dec 31, 2023 10-K 2025-03-20
Q3 2023 -$26.4M -$6.34M -$3.78M -147% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$22.7M -$9.84M -$8.99M -1057% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$13.7M -$7.48M -$13M -234% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$640K -$2.79M +$11.7M +80.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-15
Q3 2022 -$12.4M -$2.57M +$13.4M +84% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$25.8M -$850K +$2.81M +76.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 -$28.6M $5.56M +$9.1M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$37.7M -$14.5M Oct 1, 2021 Dec 31, 2021 8-K 2023-10-03
Q3 2021 -$16M -$13M -436% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$3.66M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 -$3.53M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q3 2020 -$2.99M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-30

Biofrontera Inc. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$17.8M +$2.37M +11.8% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-20
2023 -$20.1M -$19.5M -3045% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-20
2022 -$640K +$37.1M +98.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-15
2021 -$37.7M -$26.7M -243% Jan 1, 2021 Dec 31, 2021 8-K 2023-10-03
2020 -$11M Jan 1, 2020 Dec 31, 2020 10-K 2022-04-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.